Nasdaq, Inc.

Nasdaq’s 2026 10-Q MD&A, or Management’s Discussion and Analysis of Financial Condition and Results of Operations, offers a lean narrative, frequently directing readers to other sections for key disclosures. For instance, discussions of off-balance sheet arrangements are explicitly referred to Note 14, “Clearing Operations,” for non-cash default fund contributions and margin deposits, and Note 17, “Commitments, Contingencies and Guarantees,” for guarantees and credit facilities. This approach emphasizes the interconnectedness of the filing’s components, requiring a full read beyond just Item 7. Within Item 3, the company also notes its exposure to market risks such as interest rate risk and foreign currency exchange rate risk, alongside credit risk, arising from its operating, investing, and financing activities. This highlights the diverse financial exposures inherent in its business model.

The forensic scores present a mixed but generally robust picture. The Beneish M-Score, Beneish’s 1999 eight-ratio earnings-manipulation detector, registers at -2.4345, which is below the -1.78 threshold, suggesting no elevated risk of earnings manipulation based on its accounting choices. Altman’s Z″, Altman’s 1968 bankruptcy-distress index, sits at 2.49, placing it within the 1.10–2.60 “grey” zone, indicating neither clear distress nor outright safety, but rather a need for continued monitoring of its financial health. Conversely, the Piotroski F-Score, Piotroski’s 2000 9-point fundamental strength scan, comes in at a perfect 9.0, signaling strong fundamental health across its profitability, leverage, liquidity, and operating efficiency criteria. This perfect score suggests a company performing well on traditional financial metrics.

Item 7’s discussion of off-balance sheet arrangements is notable for its brevity, explicitly referring the reader to specific financial statement notes for details. This includes Note 14, “Clearing Operations,” for non-cash default fund contributions and margin deposits received, and Note 17, “Commitments, Contingencies and Guarantees,” for guarantees issued and credit facilities available. Such cross-referencing is standard practice, but it underscores that a complete understanding of the company’s financial position, particularly regarding contingent liabilities and potential future obligations, requires diligent navigation beyond the MD&A itself. These arrangements can represent significant exposures not immediately apparent from the primary financial statements alone, making the detailed notes crucial for a comprehensive forensic review.

This filing provides a snapshot of Nasdaq’s reported financial condition and management’s perspective on key risks and financial disclosures for the quarter ended March 31, 2026. It offers insights into the company’s accounting practices and the transparency of its reporting, particularly through the explicit cross-referencing of critical financial details to other notes. What it does not provide is a definitive answer regarding the security’s market valuation or its future trajectory amidst evolving market dynamics. That assessment requires external analysis of competitive landscapes, regulatory changes, and broader economic trends, which are beyond the scope of this particular 10-Q’s disclosures. The document primarily serves as a factual account of the company’s financial state, not a predictive tool for investment outcomes.